Compounds > 8-(n,n-diethylamino)octyl-3,4,5-trimethoxybenzoate
Page last updated: 2024-11-05

8-(n,n-diethylamino)octyl-3,4,5-trimethoxybenzoate and Insulinoma

8-(n,n-diethylamino)octyl-3,4,5-trimethoxybenzoate has been researched along with Insulinoma in 2 studies

8-(N,N-diethylamino)octyl-3,4,5-trimethoxybenzoate: intracellular calcium antagonist; RN given refers to parent cpd

Insulinoma: A benign tumor of the PANCREATIC BETA CELLS. Insulinoma secretes excess INSULIN resulting in HYPOGLYCEMIA.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Szewczyk, A1
De Weille, JR1
Lazdunski, M1
Pian-Smith, MC1
Yada, T1
Yaney, GC1
Abdel el Motal, SM1
Wiedenkeller, DE1
Sharp, GW1

Other Studies

2 other studies available for 8-(n,n-diethylamino)octyl-3,4,5-trimethoxybenzoate and Insulinoma

ArticleYear
TMB-8 (8-(N,N-diethylamino) octyl-3,4,5-trimethoxybenzoate) inhibits the ATP-sensitive K+ channel.
    European journal of pharmacology, 1992, Jun-05, Volume: 226, Issue:2

    Topics: Adenosine Triphosphate; Calcium Channel Blockers; Diazoxide; Electrophysiology; Gallic Acid; Insulin

1992
Mobilization of Ca2+ from intracellular stores of pancreatic beta-cells by the calcium store blocker TMB-8.
    Endocrinology, 1988, Volume: 123, Issue:4

    Topics: Animals; Calcium; Calcium Channel Blockers; Cell Line; Gallic Acid; Insulin; Insulin Secretion; Insu

1988